...
首页> 外文期刊>World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons >Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study.
【24h】

Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study.

机译:经皮射频消融与部分肝切除术治疗多中心小肝细胞癌:一项非随机对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The aim of this study was to compare the results of percutaneous radiofrequency ablation (RFA) with those of partial hepatectomy (PH) in the treatment of multicentric small hepatocellular carcinomas (HCCs). With advances in RFA, it is not known whether the minimally invasive approach with percutaneous RFA could attain comparable survival outcomes but with a lower morbidity in patients with multicentric HCCs. METHODS: From January 2002 and December 2007, 159 patients who had two or three HCCs, with the largest tumor no more than 5 cm in diameter, had no major vascular invasion or extrahepatic metastases, and were treated with either PH (n = 73) or RFA (n = 86) were included in the study. RESULTS: There was no procedure-related mortality in both groups of patients. Major complications happened significantly more often after PH than after RFA (19.2 vs. 8.1%). The hospital stay was significantly longer after PH than after RFA (median = 9 vs. 3 days). The 1-, 3-, and 5-year overall survival rates for the PH and RFA groups were 91.8, 68.7, 44.5% and 94.2, 64.4, 21.2%, respectively. The corresponding disease-free survival rates for the two groups were 62.1, 33.6, 3.6% and 29.4, 2.7, 0%, respectively. The PH group had significantly longer overall survival and disease-free survival than the RFA group. CONCLUSIONS: PH resulted in better survival outcomes than RFA for patients with multicentric small HCCs. However, RFA had the benefits of lower procedure-related morbidity and shorter hospital stay.
机译:背景:本研究的目的是比较经皮射频消融(RFA)与部分肝切除术(PH)在多中心小肝细胞癌(HCC)中的治疗结果。随着RFA的发展,目前尚不清楚经皮RFA的微创方法能否获得可比的生存结果,但多中心HCC患者的发病率更低。方法:从2002年1月至2007年12月,有159例患有2或3例HCC的患者,其最大肿瘤直径不超过5厘米,没有大的血管侵犯或肝外转移,并接受了任一PH的治疗(n = 73)或RFA(n = 86)纳入研究。结果:两组患者均无与手术相关的死亡率。 PH后发生重大并发症的频率明显高于RFA后发生的频率(19.2%vs. 8.1%)。 PH后的住院时间明显长于RFA后(中位数为9天vs. 3天)。 PH和RFA组的1年,3年和5年总生存率分别为91.8、68.7、44.5%和94.2、64.4、21.2%。两组相应的无病生存率分别为62.1、33.6、3.6%和29.4、2.7、0%。与RFA组相比,PH组的总生存期和无病生存期明显更长。结论:对于多中心小肝癌患者,PH优于RFA。然而,RFA具有降低与手术相关的发病率和缩短住院时间的好处。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号